A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

A C Rawstron; C Fazi; A Agathangelidis; N Villamor; R Letestu; J Nomdedeu; C Palacio; O Stehlikova; K-A Kreuzer; S Liptrot; D O"Brien; R M de Tute; I Marinov; M Hauwel; M Spacek; J Dobber; A P Kater; P Gambell; A Soosapilla; G Lozanski; Gabriele Brachtl; K Lin; J Boysen; C Hanson; J L Jorgensen; M Stetler-Stevenson; C Yuan; H E Broome; L Rassenti; F Craig; J Delgado; C Moreno; F Bosch; Alexander Egle; M Doubek; S Pospisilova; S Mulligan; D Westerman; C M Sanders; R Emerson; H S Robins; I Kirsch; T Shanafelt; A Pettitt; T J Kipps; W G Wierda; F Cymbalista; M Hallek; P Hillmen; E Montserrat; P Ghia

doi:10.1038/leu.2015.313

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

A C Rawstron, C Fazi, A Agathangelidis, N Villamor, R Letestu, J Nomdedeu, C Palacio, O Stehlikova, K-A Kreuzer, S Liptrot, D O"Brien, R M de Tute, I Marinov, M Hauwel, M Spacek, J Dobber, A P Kater, P Gambell, A Soosapilla, G LozanskiGabriele Brachtl (Co-author), K Lin, J Boysen, C Hanson, J L Jorgensen, M Stetler-Stevenson, C Yuan, H E Broome, L Rassenti, F Craig, J Delgado, C Moreno, F Bosch, Alexander Egle (Co-author), M Doubek, S Pospisilova, S Mulligan, D Westerman, C M Sanders, R Emerson, H S Robins, I Kirsch, T Shanafelt, A Pettitt, T J Kipps, W G Wierda, F Cymbalista, M Hallek, P Hillmen, E Montserrat, P Ghia

Research output: Contribution to journal › Original Article › peer-review

171 Citations (Web of Science)

Original language	English
Pages (from-to)	929-936
Journal	LEUKEMIA
Volume	30
Issue number	4
DOIs	https://doi.org/10.1038/leu.2015.313
Publication status	Published - 2016

Keywords

ASSAY
QUANTIFICATION
RITUXIMAB
SURVIVAL
THERAPY
ERADICATION
EXPRESSION
GUIDELINES
DIAGNOSIS
TRIAL

Access to Document

10.1038/leu.2015.313

Cite this

Rawstron, A. C., Fazi, C., Agathangelidis, A., Villamor, N., Letestu, R., Nomdedeu, J., Palacio, C., Stehlikova, O., Kreuzer, K.-A., Liptrot, S., O"Brien, D., de Tute, R. M., Marinov, I., Hauwel, M., Spacek, M., Dobber, J., Kater, A. P., Gambell, P., Soosapilla, A., ... Ghia, P. (2016). A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. LEUKEMIA , 30(4), 929-936. https://doi.org/10.1038/leu.2015.313

Rawstron, A C ; Fazi, C ; Agathangelidis, A et al. / A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. In: LEUKEMIA 2016 ; Vol. 30, No. 4. pp. 929-936.

@article{2710e356857e40a881465733e41d6b08,

title = "A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.",

keywords = "ASSAY, QUANTIFICATION, RITUXIMAB, SURVIVAL, THERAPY, ERADICATION, EXPRESSION, GUIDELINES, DIAGNOSIS, TRIAL",

author = "Rawstron, {A C} and C Fazi and A Agathangelidis and N Villamor and R Letestu and J Nomdedeu and C Palacio and O Stehlikova and K-A Kreuzer and S Liptrot and D O{"}Brien and {de Tute}, {R M} and I Marinov and M Hauwel and M Spacek and J Dobber and Kater, {A P} and P Gambell and A Soosapilla and G Lozanski and Gabriele Brachtl and K Lin and J Boysen and C Hanson and Jorgensen, {J L} and M Stetler-Stevenson and C Yuan and Broome, {H E} and L Rassenti and F Craig and J Delgado and C Moreno and F Bosch and Alexander Egle and M Doubek and S Pospisilova and S Mulligan and D Westerman and Sanders, {C M} and R Emerson and Robins, {H S} and I Kirsch and T Shanafelt and A Pettitt and Kipps, {T J} and Wierda, {W G} and F Cymbalista and M Hallek and P Hillmen and E Montserrat and P Ghia",

note = "A C Rawstron 1, C Fazi 2, A Agathangelidis 2, N Villamor 3, R Letestu 4, J Nomdedeu 5, C Palacio 6, O Stehlikova 7, K-A Kreuzer 8, S Liptrot 9, D O{\textquoteright}Brien 9, R M de Tute 1, I Marinov 10, M Hauwel 11, M Spacek 12, J Dobber 13, A P Kater 13, P Gambell 14, A Soosapilla 15, G Lozanski 16, G Brachtl 17,18, K Lin 19, J Boysen 20, C Hanson 20, J L Jorgensen 21, M Stetler-Stevenson 22, C Yuan 22, H E Broome 23, L Rassenti 23, F Craig 24, J Delgado 3, C Moreno 5, F Bosch 6, A Egle 17, M Doubek 7, S Pospisilova 7, S Mulligan 25, D Westerman 14, C M Sanders 26, R Emerson 26, H S Robins 26, I Kirsch 26, T Shanafelt 20, A Pettitt 19, T J Kipps 23, W G Wierda 21, F Cymbalista 4, M Hallek8, P Hillmen 27, E Montserrat 3 and P Ghia 2,28 on behalf of ERIC, European Research Initiative on CLL 17 3rd Medical Department, Paracelsus Medical University, Salzburg, Austria 18 Experimental & Clinical Cell Therapy Institute, Spinal Cord & Tissue Regeneration Center, Paracelsus Medical University, Salzburg, Austria",

year = "2016",

doi = "10.1038/leu.2015.313",

language = "English",

volume = "30",

pages = "929--936",

journal = "LEUKEMIA ",

issn = "0887-6924",

number = "4",

}

Rawstron, AC, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O"Brien, D, de Tute, RM, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, AP, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, JL, Stetler-Stevenson, M, Yuan, C, Broome, HE, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, CM, Emerson, R, Robins, HS, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, TJ, Wierda, WG, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E & Ghia, P 2016, 'A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.', LEUKEMIA , vol. 30, no. 4, pp. 929-936. https://doi.org/10.1038/leu.2015.313

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. / Rawstron, A C; Fazi, C; Agathangelidis, A et al.
In: LEUKEMIA , Vol. 30, No. 4, 2016, p. 929-936.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

AU - Rawstron, A C

AU - Fazi, C

AU - Agathangelidis, A

AU - Villamor, N

AU - Letestu, R

AU - Nomdedeu, J

AU - Palacio, C

AU - Stehlikova, O

AU - Kreuzer, K-A

AU - Liptrot, S

AU - O"Brien, D

AU - de Tute, R M

AU - Marinov, I

AU - Hauwel, M

AU - Spacek, M

AU - Dobber, J

AU - Kater, A P

AU - Gambell, P

AU - Soosapilla, A

AU - Lozanski, G

AU - Brachtl, Gabriele

AU - Lin, K

AU - Boysen, J

AU - Hanson, C

AU - Jorgensen, J L

AU - Stetler-Stevenson, M

AU - Yuan, C

AU - Broome, H E

AU - Rassenti, L

AU - Craig, F

AU - Delgado, J

AU - Moreno, C

AU - Bosch, F

AU - Egle, Alexander

AU - Doubek, M

AU - Pospisilova, S

AU - Mulligan, S

AU - Westerman, D

AU - Sanders, C M

AU - Emerson, R

AU - Robins, H S

AU - Kirsch, I

AU - Shanafelt, T

AU - Pettitt, A

AU - Kipps, T J

AU - Wierda, W G

AU - Cymbalista, F

AU - Hallek, M

AU - Hillmen, P

AU - Montserrat, E

AU - Ghia, P

N1 - A C Rawstron 1, C Fazi 2, A Agathangelidis 2, N Villamor 3, R Letestu 4, J Nomdedeu 5, C Palacio 6, O Stehlikova 7, K-A Kreuzer 8, S Liptrot 9, D O’Brien 9, R M de Tute 1, I Marinov 10, M Hauwel 11, M Spacek 12, J Dobber 13, A P Kater 13, P Gambell 14, A Soosapilla 15, G Lozanski 16, G Brachtl 17,18, K Lin 19, J Boysen 20, C Hanson 20, J L Jorgensen 21, M Stetler-Stevenson 22, C Yuan 22, H E Broome 23, L Rassenti 23, F Craig 24, J Delgado 3, C Moreno 5, F Bosch 6, A Egle 17, M Doubek 7, S Pospisilova 7, S Mulligan 25, D Westerman 14, C M Sanders 26, R Emerson 26, H S Robins 26, I Kirsch 26, T Shanafelt 20, A Pettitt 19, T J Kipps 23, W G Wierda 21, F Cymbalista 4, M Hallek8, P Hillmen 27, E Montserrat 3 and P Ghia 2,28 on behalf of ERIC, European Research Initiative on CLL 17 3rd Medical Department, Paracelsus Medical University, Salzburg, Austria 18 Experimental & Clinical Cell Therapy Institute, Spinal Cord & Tissue Regeneration Center, Paracelsus Medical University, Salzburg, Austria

PY - 2016

Y1 - 2016

KW - ASSAY

KW - QUANTIFICATION

KW - RITUXIMAB

KW - SURVIVAL

KW - THERAPY

KW - ERADICATION

KW - EXPRESSION

KW - GUIDELINES

KW - DIAGNOSIS

KW - TRIAL

U2 - 10.1038/leu.2015.313

DO - 10.1038/leu.2015.313

M3 - Original Article

C2 - 26639181

SN - 0887-6924

VL - 30

SP - 929

EP - 936

JO - LEUKEMIA

JF - LEUKEMIA

IS - 4

ER -

Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J et al. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. LEUKEMIA . 2016;30(4):929-936. doi: 10.1038/leu.2015.313